The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2021 | Personalized medicine in NETs
Peter M. Anderson, MD, PhD , Cleveland Clinic, Cleveland, OH, talks on the development of personalized medicine approaches for patients with neuroendocrine tumors (NETs), and the importance of targeting unique, targetable somatic mutations as well as the potential of RNA cancer vaccines for patients with NETs. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.
